Female hormonal exposures and risk of rheumatoid arthritis in the French E3N-EPIC cohort study

被引:21
作者
Salliot, Carine [1 ,2 ,3 ]
Nguyen, Yann [1 ,4 ]
Gusto, Gaelle [1 ,5 ]
Gelot, Amandine [1 ,5 ]
Gambaretti, Juliette [1 ,5 ]
Mariette, Xavier [3 ,6 ]
Boutron-Ruault, Marie-Christine [1 ,5 ]
Seror, Raphaele [3 ,6 ]
机构
[1] Univ Paris Saclay, Ctr Res Epidemiol & Populat Hlth CESP, U1018, INSERM, Villejuif, France
[2] Ctr Hosp Reg Orleans, Rheumatol Dept, Orleans, France
[3] Univ Paris Saclay, Ctr Immunol Viral Infect & Autoimmune Dis IMVA, INSERM, U1184, Paris, France
[4] Univ Paris, Dept Internal Med, Hop Beaujon, AP HP Nord, Clichy, France
[5] Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France
[6] Univ Paris Saclay, Hop Bicetr, AP HP, Rheumatol Dept, Paris, France
关键词
rheumatoid arthritis; prospective cohort; female hormonal exposures; BREAST-CANCER RISK; REPLACEMENT THERAPY; WOMEN; PARITY; METAANALYSIS; MENOPAUSE; ONSET; TIME; SEX; E3N;
D O I
10.1093/rheumatology/keab101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the relationships between female hormonal exposures and risk of RA in a prospective cohort of French women. Methods. E3N (Etude Epidemiologique aupres des femmes de la Mutuelle generale de l'Education Nationale) is an on-going French prospective cohort that included 98 995 women aged 40-65 years in 1990. Every 2-3years, women completed mailed questionnaires on their lifestyles, reproductive factors and health conditions. Cox proportional hazards regression models were used to determine factors associated with risk of incident RA, with age as the time scale, adjusted for known risk factors of RA, and considering endogenous and exogenous hormonal factors. Hazard ratios (HRs) and 95% CIs were estimated. Effect modification by smoking history was investigated. Results. A total of 698 incident cases of RA were ascertained among 78 452 women. In multivariable-adjusted Cox regression models, risk of RA was increased with early age at first pregnancy (<22 vs >= 27 years; HR=1.34; 95% CI 1.0, 1.7) and menopause (<= 45 vs >= 53 years; HR=1.40; 95% CI 1.0, 1.9). For early menopause, the association was of similar magnitude in ever and never smokers, although the association was statistically significant only in ever smokers (HR=1.54; 95% CI 1.0, 2.3). We found a decreased risk in nulliparous women never exposed to smoking (HR=0.44; 95% CI 0.2, 0.8). Risk of RA was inversely associated with exposure to progestogen only in perimenopause (>24 vs 0 months; multi-adjusted HR=0.77; 95% CI 0.6, 0.9). Conclusions. These results suggest an effect of both endogenous and exogenous hormonal exposures on RA risk and phenotype that deserves further investigation.
引用
收藏
页码:4790 / 4800
页数:11
相关论文
共 35 条
  • [1] Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis
    Alpizar-Rodriguez, Deshire
    Mueller, Rudiger B.
    Moller, Burkhard
    Dudler, Jean
    Ciurea, Adrian
    Zufferey, Pascal
    Kyburz, Diego
    Walker, Ulrich A.
    Von Muhlenen, Ines
    Roux-Lombard, Pascale
    Mahler, Michael
    Lamacchia, Celine
    Courvoisier, Delphine S.
    Gabay, Cem
    Finckh, Axel
    [J]. RHEUMATOLOGY, 2017, 56 (09) : 1579 - 1585
  • [2] The role of female hormonal factors in the development of rheumatoid arthritis
    Alpizar-Rodriguez, Deshire
    Pluchino, Nicola
    Canny, Geraldine
    Gabay, Cem
    Finckh, Axel
    [J]. RHEUMATOLOGY, 2017, 56 (08) : 1254 - 1263
  • [3] Association Between Menopausal Factors and the Risk of Seronegative and Seropositive Rheumatoid Arthritis: Results From the Nurses' Health Studies
    Bengtsson, Camilla
    Malspeis, Susan
    Orellana, Cecilia
    Sparks, Jeffrey A.
    Costenbader, Karen H.
    Karlson, Elizabeth W.
    [J]. ARTHRITIS CARE & RESEARCH, 2017, 69 (11) : 1676 - 1684
  • [4] Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study
    Berglin, E.
    Kokkonen, H.
    Einarsdottir, E.
    Agren, A.
    Dahlqvist, S. Rantapaa
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2010, 39 (06) : 454 - 460
  • [5] Beydoun HA, 2013, MENOPAUSE, V20, P930, DOI [10.1097/GME.0b013e3182a14372, 10.1097/gme.0b013e3182a14372]
  • [6] Oral contraceptives and rheumatoid arthritis: Results from a primary care-based incident case-control study
    Brennan, P
    Bankhead, C
    Silman, A
    Symmons, D
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1997, 26 (06) : 817 - 823
  • [7] Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register
    Camacho, E. M.
    Harrison, M.
    Farragher, T. M.
    Lunt, M.
    Bunn, D. K.
    Verstappen, S. M. M.
    Symmons, D. P. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) : 642 - 645
  • [8] Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study
    Cervenka, I.
    Mahamat-Saleh, Y.
    Savoye, I.
    Dartois, L.
    Boutron-Ruault, M. C.
    Fournier, A.
    Kvaskoff, M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (10) : 2390 - 2399
  • [9] Fertility drugs and cutaneous melanoma risk: a French prospective cohort study
    Cervenka, Iris
    Al Rahmoun, Marie
    Mahamat-Saleh, Yahya
    Boutron-Ruault, Marie-Christine
    Fournier, Agnes
    Kvaskoff, Marina
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (02) : 182 - 185
  • [10] Breastfeeding and Risk of Rheumatoid Arthritis: A Systematic Review and Metaanalysis
    Chen, Haiyan
    Wang, Jing
    Zhou, Wang
    Yin, Huabin
    Wang, Meimei
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (09) : 1563 - 1569